NASDAQ:TLX Telix Pharmaceuticals Limited American Depositary Shares (TLX) Stock Price, News & Analysis $16.99 -0.17 (-0.99%) Closing price 03:59 PM EasternExtended Trading$16.99 0.00 (0.00%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsTrends About Telix Pharmaceuticals Limited American Depositary Shares Stock (NASDAQ:TLX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get TLX alerts:Sign Up Key Stats Today's Range$16.95▼$17.7950-Day Range$14.56▼$20.9352-Week Range$14.01▼$30.36Volume18,233 shsAverage Volume27,815 shsMarket Capitalization$5.72 billionP/E RatioN/ADividend YieldN/APrice Target$22.00Consensus RatingBuy Company OverviewTelix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.Read More… Remove Ads Receive TLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Telix Pharmaceuticals Limited American Depositary Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address TLX Stock News HeadlinesTelix Adds Lead-212 Isotope Production CapabilityMarch 12 at 6:41 PM | globenewswire.comInvestor Webinar: Telix Therapeutics Urology Showcase and Expert ForumMarch 3, 2025 | globenewswire.comPlease don’t die on me"Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune. After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him.March 13, 2025 | Porter & Company (Ad)FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority ReviewFebruary 25, 2025 | globenewswire.comRecruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in MiamiFebruary 25, 2025 | globenewswire.comAustralia's Telix Pharmaceuticals scales record peak on upbeat revenue forecastFebruary 20, 2025 | reuters.comTelix Pharmaceuticals Limited 2024 Q4 - Results - Earnings Call PresentationFebruary 20, 2025 | seekingalpha.comTelix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 BillionFebruary 20, 2025 | globenewswire.comSee More Headlines TLX Stock Analysis - Frequently Asked Questions How have TLX shares performed this year? Telix Pharmaceuticals Limited American Depositary Shares' stock was trading at $15.40 at the start of the year. Since then, TLX shares have increased by 10.9% and is now trading at $17.0710. View the best growth stocks for 2025 here. When did Telix Pharmaceuticals Limited American Depositary Shares IPO? Telix Pharmaceuticals Limited American Depositary Shares (TLX) raised $202 million in an initial public offering (IPO) on Friday, June 14th 2024. The company issued 17,000,000 shares at a price of $11.87 per share. How do I buy shares of Telix Pharmaceuticals Limited American Depositary Shares? Shares of TLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today3/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TLX Previous SymbolNASDAQ:TLX CIK2007191 Webwww.telixpharma.com Phone61-3-9093-3855FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$22.00 High Stock Price Target$22.00 Low Stock Price Target$22.00 Potential Upside/Downside+28.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$783.21 million Price / Sales7.38 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares336,872,000Free FloatN/AMarket Cap$5.78 billion OptionableN/A BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:TLX) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals Limited American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
